Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2024

Percutaneous Treatment of Tricuspid Regurgitation with the Novel TriFlO® Device: Technology and Clinical Update

Presenter: Gian Paolo Ussia

October 29, 2024

Presentation TCT 2024

Early Human Results with the Versa Tricuspid Valve Leaflet Extension System

Presenter: Neil Fam

October 29, 2024

Presentation TCT 2024

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Presenter: Stefan Anker

October 27, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique

Presenter: Giulia Passaniti

June 05, 2024

Presentation NY Valves 2024

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Presenter: Guillaume Bonnet

June 05, 2024

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Presentation Miami Valves 2024

Testing the Limits of TEER Beyond COAPT

Presenter: Diego H. González-Bravo

February 03, 2024

Presentation Miami Valves 2024

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

Presenter: Solomon A. Seifu

February 03, 2024

Advertisement

Percutaneous Treatment of Tricuspid Regurgitation with the Novel TriFlO® Device: Technology and Clinical Update

Early Human Results with the Versa Tricuspid Valve Leaflet Extension System

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Testing the Limits of TEER Beyond COAPT

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content